Skip to content
Biodatica
Start free

Investigator

Rebecca L Berdeaux

CELLCHORUS INC. · funded by NCI, NCATS

Companies
3

Resolved onto their grants.

Grants
4

Federal awards on file.

Non-dilutive funding
$3.5M

Summed across those awards.

First award
May 1, 2024

Latest Sep 1, 2025.

Companies from this work

Pre-ticker companies the crosswalk resolved onto a grant filed under this investigator. Momentum shows for the therapeutic areas your seat covers; open a dossier for the full crosswalk.

Grant record

Federal awards filed under this investigator name, newest first. Each links to the public record where the awarding agency publishes one.

  1. R43

    Functional signatures of post-infusion CAR T cells for early indication of patient response

    $400k

    Sep 1, 2025NCICELLCHORUS INC.NIH RePORTER · 11186616 (opens the source filing in a new tab)

  2. R42

    LF-TIMING: Large-scale label-free profiling of cell-cell interactions

    $1.1M

    Aug 8, 2024NCATSCELLCHORUS INC.NIH RePORTER · 11167085 (opens the source filing in a new tab)

  3. R44

    Integrated assays of single-cell dynamics and molecular phenotype for cell therapy manufacturing

    $984k

    May 1, 2024NCATSCELLCHORUS INC.NIH RePORTER · 11179716 (opens the source filing in a new tab)

  4. R44

    Integrated assays of single-cell dynamics and molecular phenotype for cell therapy manufacturing

    $1.0M

    May 1, 2024NCATSCELLCHORUS INC.NIH RePORTER · 11322109 (opens the source filing in a new tab)

This page aggregates public U.S. federal grant records filed under one investigator name and the companies Biodatica has resolved onto them. Names are shown as the awarding agency filed them; grant awards are non-dilutive federal funding, not equity or valuation. Distinct people who file under the same name would appear together here. It is informational only and not investment advice. Methodology · Data sources